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High Frequency Components of 
Hemodynamic Shear Stress Profiles 
are a Major Determinant of Shear-
Mediated Platelet Activation in 
Therapeutic Blood Recirculating 
Devices
Filippo Consolo1,2, Jawaad Sheriff3, Silvia Gorla1, Nicolò Magri1, Danny Bluestein3,  
Federico Pappalardo2, Marvin J. Slepian3,4, Gianfranco B. Fiore  1 & Alberto Redaelli  1
We systematically analyzed the relative contributions of frequency component elements of 
hemodynamic shear stress waveforms encountered in cardiovascular blood recirculating devices as 
to overall platelet activation over time. We demonstrated that high frequency oscillations are the 
major determinants for priming, triggering and yielding activated “prothrombotic behavior” for 
stimulated platelets, even if the imparted shear stress has low magnitude and brief exposure time. 
Conversely, the low frequency components of the stress signal, with limited oscillations over time, 
did not induce significant activation, despite being of high magnitude and/or exposure time. In vitro 
data were compared with numerical predictions computed according to a recently proposed numerical 
model of shear-mediated platelet activation. The numerical model effectively resolved the correlation 
between platelet activation and the various frequency components examined. However, numerical 
predictions exhibited a different activation trend compared to experimental results for different time 
points of a stress activation sequence. With this study we provide a more fundamental understanding 
for the mechanobiological responsiveness of circulating platelets to the hemodynamic environment 
of cardiovascular devices, and the importance of these environments in mediating life-threatening 
thromboembolic complications associated with shear-mediated platelet activation. Experimental data 
will guide further optimization of the thromboresistance of cardiovascular implantable therapeutic 
devices.
Hemodynamic shear stress interacts with and impacts platelets leading to a spectrum of responses ranging from 
altered biochemical signaling, to activation, to complete destruction with microparticle formation1. Exposure to 
fluid shear stress alone has been demonstrated to activate and aggregate platelets irreversibly, without the need for 
exogenous agonists2. Shear-mediated platelet activation (SMPA) shows a consistent dose and time response, with 
stoichiometric characteristics similar to those of chemical agonists3–6.
In particular, the supraphysiological levels of hemodynamic shear stress, i.e. “hypershear”, exerted by thera-
peutic mechanical cardiovascular blood recirculating devices (BRDs), such as ventricular assist devices (VADs), 
the total artificial heart, and prosthetic heart valves (PHVs), expose circulating platelets to severe mechanical 
loading regimens, enhancing SMPA7–9. Hypershear stress in BRDs is associated with altered flow conditions, 
such as adverse pressure gradients, flow separation, vortex formation, vortex shedding and turbulence, which also 
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contribute to platelet activation8. Two further effects contribute to SMPA in BRDs: first, platelet damage increases 
with repetitive passes through a device, suggesting that platelets accumulate cyclic shear stress exposures; second, 
shear stress also has a sensitizing effect on platelets, so that platelets exposed to very high shear stress - even for 
brief exposures, such as during passage through BRDs - continue to activate despite subsequent exposure to low 
shear stress - as is encountered downstream of BRDs - with a residual incremental response compounding that of 
the initial high shear pulses or waveforms10–12.
Shear flow-related mechanisms of SMPA are likely to have predominant implications in the development of 
thromboembolic complications in patients implanted with mechanical therapeutic BRDs13–15, which contribute 
significantly to overall morbidity and mortality16, 17.
Due to the complex nature of hemodynamic shear stress patterns in BRDs, characterized by differing and 
highly time-varying shear stress magnitudes, pulse durations, directions and temporal oscillations, the identi-
fication of the dominant hemodynamic characteristics that drive altered platelet function is challenging. In last 
few years, different approaches and methodologies have been developed to elucidate the mechanisms driving 
SMPA and to identify possible design solutions to refine and minimize the device-associated thrombogenicity. 
These include numeric and experimental tools, often used in combination, to model shear stress waveforms and 
to predict and characterize the phenomenological platelet response18–20.
In the context of this research area, newer, and progressively more refined phenomenological models of SMPA 
have been advanced21, 22. More recently, we defined a new class of SMPA model of the differential-type23. This 
model was based on a general reaction equation, including terms accounting for different hemodynamic char-
acteristics of the shear stress, namely the shear stress magnitude and the corresponding exposure time, which 
together define the stress accumulation (SA, i.e., the integral of the scalar shear stress over time), and the stress 
rate (SR, i.e. the shear stress loading rate, or the variation of the shear stress over time). This model success-
fully described experimental observations of platelet response to a variety of time-constant and dynamic shear 
stress conditions, also properly describing platelet sensitization23. Moreover, this model allowed prediction of the 
logistic saturation of platelet activation. In fact, as observed experimentally, at high numbers of repetitive stimu-
lation cycles, the activation rate progressively vanishes and platelets reach a maximum activation level asymptoti-
cally23. However, the model formulation was defined through in vitro studies that examined the platelet activation 
response to synthetic shear stress loading waveforms that differed significantly from loading conditions relevant 
to devices, thus warranting further investigation aimed at validating its true strength.
In the present study, we evaluated the dynamics of SMPA in vitro, induced by realistic, i.e., BRD-like, hemody-
namic shear stress patterns. We hypothesized that deconstructing and analyzing clinically accurate hemodynamic 
stress waveforms associated with platelet passage through BRDs would yield component elements, including: the 
distribution of frequency components, SA and SR, that would be more predictive of platelet activation than use 
of the waveform alone as a whole. As such, first we exposed platelets to shear flow mechanical loading character-
istics of a recently developed trileaflet PHV and measured the dynamics of activation in response to repetitive 
shear stress exposure. We focused our analysis on characterizing the mutual contribution of SA and SR on SMPA. 
For this aim, we used principles of signal frequency content analysis. In fact, both SA and SR are hemodynamic 
characteristics that can fundamentally be described by the frequency spectrum of a given shear stress waveform. 
In detail, while low-frequency components of the spectrum are associated with a dominant contribution of SA 
(high magnitude and exposure time, low temporal oscillation), high-frequency components are associated with 
high SR (high temporal oscillation, low magnitude and exposure time). In view of that, we selected specific fre-
quency components of the spectrum of two PHV-shear stress profiles (from low- to high-frequency components) 
to obtain a set of test-curves yielding different values of SA and SR, respectively.
We then tested the predictive capability of the differential-type numerical model23 of SMPA in response to 
the realistic PHV shear stress waveforms by comparing experimental data with numerical predictions of platelet 
activation. Moreover, we compared the experimental dynamics of platelet activation of the extracted frequency 
waveforms with numerical predictions, to test the ability of the numerical model to discriminate between the 
distinctive effects mediated by SA and SR and to properly balance their mutual contribution to SMPA.
Methods
Definition of the test-curves. Two hemodynamic shear stress profiles characteristics of a recently devel-
oped trileaflet polymeric PHV24 were utilized to define a set of paradigmatic BRD-like test-curves for both 
the experimental as well as the numerical characterization of the platelet response. These profiles are named 
Original_A and Original_B, and are shown in Fig. 1A. Those curves were extracted by combining: i) a Fluid 
Structure Interaction (FSI) algorithm allowing to model the valve kinematics over consecutive cardiac cycles 
and ii) a Lagrangian formulation to track the trajectory of tens of thousands of injected platelets passing through 
specific regions of interest (ROI) of the valve24. Then, a Probability Density Function (PDF) of the corresponding 
shear stress curves was built (i.e., the PHV thrombogenic footprint) and the most frequently occurring (mode) 
SA value of the PDF was selected as the most representative shear stress pattern of each ROI24 (i.e., the Original_A 
and Original_B curves).
The frequency content of Original_A and Original_B was extracted through Fourier analysis, where a Fast 
Fourier Transform (FFT) algorithm was performed to convert the two curves from their time domain to a rep-
resentation in the frequency domain25. Principal frequency components of the two shear stress waveforms were 
identified from the power spectrum (PS) curve (Fig. 1B). The PS describes the distribution of the principal fre-
quency components of a given signal and the power associated with the signal at each frequency and is calculated 
as the square of the absolute values of the FFT coefficients. The PS was calculated with a frequency-step equal to 
the reciprocal of the time period (Δt) of the considered curves. The PS for Original_A and Original_B, which 
have a Δt equal to 0.5 s24, was thus computed with a 2-Hz frequency step. The PS was then discretized in fre-
quency bands (FBs) using the “find peaks” tool of Matlab (The MathWorks, Inc., USA). Each FB was calculated 
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around each of the identified principal frequency component of the PS, corresponding to the local maxima 
of the spectrum. In detail, each FB was calculated as the full width at half-maximum amplitude of each peak. 
According to our analysis, for each waveform, four principal components (Peaks) were identified (red triangles in 
Fig. 1B). Data on FB values and power signal (P) for each of the four peaks (Peaks 1–4) identified from the PS of 
Original_A and Original_B are reported in Table 1.
For both waveforms (i.e., Original_A and Original_B) three different Peaks were selected to cover the full 
frequency range, namely: i) the low-frequency peak (Peak_1A and Peak1B), ii) the medium-frequency peak 
with higher power signal (Peak_2A and Peak_3B for Original_A and Original_B, respectively), and iii) the 
high-frequency peak (Peak_4A and Peak4B), and corresponding time-domain curves were reconstructed 
through inverse FFT (Fig. 2). In this way, starting from the Original shear stress profiles, we obtained a set of 
test-curves modulating SA and SR, respectively. Moreover, a time-constant (SR = 0) and low-stress amplitude (1 
dyne/cm2) waveform was included in the data set and used as a negative control (NC); the temporal duration of 
the NC was set to 0.5 s to match that of the dynamic test waveforms.
In Table 2, we reported SA and SR values for each of the test-curves of our data set. As the considered curves 
discrete signals, their SA and SR values were calculated according to (eqs 1 and 2):
Figure 1. (A) Hemodynamic shear stress profiles characteristics of the trileaflet PHV are shown in the time-
domain: the two curves, named Original_A (left) and Original_B (right) were computed from simulated 
trajectories of platelets flowing through two selected gap regions between the leaflet and the valve annulus24, 
indicated by arrows. (B) Power spectrum (PS) of the curves allows representing Original_A (left) and 
Original_B (right) in the frequency-domain: the principal frequency components of the PS are indicated by red 
triangles (Peak_1A–4A, Peak_1B–4B).











Table 1. Frequency bands (FB) and power signal (P) of the four peaks identified from the power spectrum of 
the Original_A and Original_B curves.
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SA (eq. 1) was calculated as the integral of the scalar shear stress over time; SR (eq. 2) was calculated as the 
average shear stress time-gradient, which was selected as that representative of the time-varying characteristics 
of each curve. To calculate SR, we considered both the positive and negative variations of shear stress over time. 
Figure 2. The test-curve data set: (A) Original curves; time-domain reconstructed curves corresponding to the 
(B) low- (Peak_1A and Peak_1B), (C) medium- (Peak_2A and Peak_3B) and (D) high-frequency (Peak_4A and 
Peak_4B) component elements of the power spectrum of Original_A and Original_B; (E) the time-constant and 
low-stress amplitude negative control (NC) curve.










Table 2. Values of Stress Accumulation (SA) and Shear Stress Loading Rate (Stress Rate, SR) calculated for each 
of the test curves of our data set are compared with respect to values characteristics of the Original curves. The 
low-frequency curves (Peak_1A and 1B) show higher SA than Original curves but lower SR; SA progressively 
decreases while SR further increases in medium- (Peak_2A and 3B) and high-frequency curves (Peak_4A and 
4B). The negative control (NC) curve has the lowest SA and null SR.
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Accordingly, SR accounts for the mechanical loading exerted on platelets during both acceleration (SR > 0) and 
deceleration (SR < 0) phases of the shear stress.
As shown in the SR vs SA chart of Fig. 3, the Original waveforms, being composed of all the frequency peaks of 
the PS, are characterized by high values of both SA and SR; the low-frequency waveforms have the highest value 
of SA (even greater than that of the Original) but the lowest value of SR (except for the NC curve); SA decreases 
and the SR increases progressively with increasing frequencies, i.e., from medium-to high-frequency waveforms. 
The high-frequency waveforms have an extremely low value of SA, comparable to that of the NC curve, but 
differ significantly from NC in terms of SR values. As such, while SA is a major hemodynamic characteristic of 
low-frequency waveforms, SR becomes progressively dominant for the medium- and high-frequency curves.
Experimental characterization of the dynamics of shear-induced platelet activation. Whole 
blood (250 mL) was drawn through venipuncture from living adult bovine, collected into a blood bag 
(TERUFLEX, Terumo Corporation, Tokyo, Japan) containing 35 mL of citrate phosphate dextrose adenine 
(CPDA-1) as anticoagulant and transferred to the laboratory. Blood sampling procedures were performed in 
accordance with the European Commission directive (2010/63/UE) and with the laws and regulations on animal 
welfare enclosed in D.L.G.S. 26/14 and approved by the Italian Health Department. Purified gel-filtered platelets 
(GFP) were prepared from bovine whole blood and diluted to a standard concentration of 20,000 platelets/μl in 
a Hepes-modified Ca2+-free Tyrode’s buffer containing 0.1% fatty-acid-free bovine serum albumin, with 3 mM 
Ca2+ added 10 min prior to experiments26. Equilibrated GFP were maintained with gentle agitation at room tem-
perature and used for stimulation experiments within 4 hours of gel-filtration.
The time-domain shear stress waveforms of the data set - specifically Original_A, Peak_1A, Peak_2A, 
Peak_4A; Original_B, Peak_1B, Peak_3B, Peak_4B, and the NC (Table 2) - were programmed into a 
computer-controlled Hemodynamic Shearing Device (HSD) that was used to stimulate GFP19, 21. Each curve was 
replicated consecutively to obtain a total of 10-min of stress exposure, corresponding to 600 consecutive repeti-
tions of the shear stress profile.
For each stimulation test, 3 ml GFP were gently added to the HSD stimulation chamber and subsequently 
exposed to programmed shear stress, as outlined above. At pre-determined time-points, i.e. 2, 5 and 10 min - cor-
responding to 120, 300 and 600 repetitions - a platelet sample (50 μl) was withdrawn from the HSD and assayed 
via the modified prothrombinase Platelet Activity State (PAS) assay11, 12, 27–30, to quantify the associated level of 
activation (for details see Supplementary Information). In addition, a platelet sample was assayed immediately 
(at 0 min) after placing GFP within the HSD chamber, though prior to and without shear exposure, so to define 
baseline activation values of non-stimulated platelet samples.
GFP sampling from the HSD was performed automatically through a syringe pump (PSD/8, Hamilton, Reno, 
NV, USA). Briefly, a 250-μl glass syringe with a Luer fitting was mounted on the pump head and connected to 
the HSD stimulation chamber via a polyethelene tubing (2-mm inner diameter). The pump commands were 
programmed in LabView 2010 (National Instruments, Austin, TX, USA) and transmitted via an RS-232 port con-
nected to the pump. When the pump was operated, 50 μl of GFP were drawn from the HSD stimulation chamber 
and collected into polyethelene conical tubes; slow sampling and collection flow rates (10 μl/s) were set to avoid 
any undesired GFP activation induced by the sampling and collection steps.
Figure 3. Values of SA and SR of each of the test-curves: by selecting specific frequency components of the 
spectrum of Original curves, we obtained a set of shear stress waveforms modulating the SA and SR values. (A): 
Original_A; (B) Original_B.
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For each time-point, multiple PAS readings were performed to evaluate data consistency (n = 4). Furthermore, 
for each curve, stimulation tests were replicated with N = 3 different blood donors, on different experimental 
days, with each curve replicated twice on the same experimental day.
PAS values were plotted against time-of-stimulation to evaluate differences in the dynamics of activation 
induced by the different test-curves over time.
Numerical characterization of the dynamics of shear-induced platelet activation. Experimental 
values of platelet activation were compared with those estimated using the three-term differential numerical PAS 
model23. Briefly, the model is structured to account for experimental observations of platelet activation rate taper-




K [PAS, (s)](1 PAS) (3)0
(t)
where K0 is interpreted as the rate of stress-induced PA when PAS = 0 and τ = τ − ∈(s) (t s), s [0, t](t)  as the 
scalar stress history of the platelet up to time t.
The shear-dependent platelet activation term of eq. 3 can be further expanded into three different and distinct 
terms (eq. 4):
τ = + τ + ττ K [PAS, (s)] S(PAS, H ) F(PAS, ) G(PAS, ) (4)0
(t)
The term S(PAS, Hτ) accounts for platelet sensitization, which is dependent on the current level of activation and 
on the stress accumulation of the entire stress history, Hτ, and is defined as (eq. 5):
= ⋅τ τS(PAS, H ) S PAS H (5)r
where Sr is a constant that characterizes the sensitization response. The product of the current level of platelet 
activation and stress accumulation, PAS · Hτ, linearly correlates with sensitization, as experimentally.
The entire stress history until time t (Hτ) is defined as (eq. 6):
∫= ττH (s)ds (6)0
t
The second and third terms of eq. 4, F(PAS, τ) and G(PAS, τ ), provide nonlinear rates of activation which are 
dependent on the current levels of stress and stress rate, respectively. These contributions to the activation rate are 
nonlinear due to their explicit dependence on PAS. The specific form of the former term utilizes the 
well-established power law behavior to describe low levels of PA under constant shear stress conditions, while the 
latter term provides a properly describes the phenomenological shear rate effect on PA as experimentally deter-
mined23. These terms are defined as (eqs 7 and 8):




βF(PAS, ) C PAS (7)
1 1






G(PAS, ) C PAS (8)r
1 1
where C, α, β, Cr, δ, and γ are constants.
Numerical PAS values were computed according to constant values reported previously23 (Table 3). In addi-
tion, we systematically analyzed the contribution of each of those parameters and defined a new set of values 
(Table 3) in order improve fitting of the experimental data (see Results).
Numerical PAS values were computed for all the considered stress histories, i.e. the two Originals, the low-, 
medium- and high-frequency curves, and the NC. For each curve, PAS was calculated at 0, 2, 5 and 10-min sim-
ulated time-points, allowing comparison of numerical predictions with experimental data.
Statistical Analysis. Experimental PAS data are presented as mean ± standard deviation (SD). The 
Shapiro-Wilk normality test and the F-test of equality of variances were utilized to evaluate the data distribution; 
accordingly, results were analyzed through: i) parametric One-Way ANOVA on Ranks with Tukey’s post-hoc 
test, or the non-parametric Kruskal-Wallis One-Way ANOVA on Ranks with Dunn’s post-hoc test, to evaluate 
the dynamics of PAS over time associated with each of the tested curves, and ii) parametric Student’s t-test or the 
non-parametric Mann-Whitney U test to compare the PA level induced by different test-curves. Analyses were 
performed with Prism 7.0 (GraphPad Software, Inc., La Jolla, CA, USA). A p value < 0.05 was accepted as statis-
tically significant.
Sr C α β Cr γ δ
Original23 1.5701 × 10−7 1.4854 × 10−7 1.4854 1.4401 1.3889 × 10−4 0.5720 0.5125
Optimized 1.5701 × 10−7 1.4854 × 10−7 0.71825 0.72005 2.78 × 10−5 0.75 0.5125
Table 3. Values of the model parameters used for the numerical prediction of shear-induced platelet activation 
dynamics.
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Results
Experimental platelet activation values of HSD-stimulated platelets, as measured through the PAS assay, and 
numerical predictions of SMPA, computed according to the differential-type numerical model23, are listed in 
Table 4: data are reported for each of the defined measurement time-points (0, 2, 5 and 10 min).
Experimental dynamics of platelet activation. According to our in vitro measurements of platelet acti-
vation (Fig. 4):
 (i) The activation rate induced by the negative control (NC), which has null SR and low SA, was extremely low. 
Maximum PAS value at 10 min (PASt10) was equal to 0.74 ± 0.32% (<1%), thus indicating quite-negligible 
SMPA.
 (ii) The Original curves, yielding high values of both SA and SR, induced a progressively increasing rate of 
activation with increasing stimulation time (p < 0.0001). The maximum experimental PAS value reached at 
10 min (PASt10) was equal to 14.77 ± 1.96% and 19.62 ± 3.28% for Original_A and Original_B, respective-
ly, significantly higher than PASt10 of the NC (p < 0.001). The two curves exhibited a non-linear trend of 
activation, where the first increase of the activation rate in the 0-to-5 min stimulation phase is followed by 
a further shift of the curve slope (5-to-10 min).
 (iii) The low-frequency curves, with the highest SA but lowest SR, induced a small degree of SMPA over the 
considered stimulation period. The increase of PAS over time resulted in extremely low experimental 
PAS [%]
NC Original_A Peak_1A Peak_2A Peak_4A Original_B Peak_1B Peak_3B Peak_4B
t0
exp 0.16 ± 0.14 0.30 ± 0.31 0.03 ± 0.04 0.88 ± 0.52 0.40 ± 0.23 1.45 ± 0.70 0.30 ± 0.11 0.79 ± 0.30 0.29 ± 0.17
num 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
num_opt 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
t2
exp 0.13 ± 0.17 0.62 ± 0.14 0.39 ± 0.22 0.73 ± 0.51 0.36 ± 0.22 3.65 ± 2.60 0.78 ± 0.12 0.78 ± 0.21 3.09 ± 1.72
num 0.04 6.22 1.91 3.65 4.07 7.18 1.91 4.96 5.14
num_opt 0.02 4.72 0.79 2.09 2.44 4.80 0.79 3.23 3.34
t5
exp 0.49 ± 0.17 2.39 ± 0.55 0.54 ± 0.53 1.10 ± 0.39 0.62 ± 0.35 6.52 ± 3.02 1.17 ± 0.70 2.55 ± 1.74 5.69 ± 1.96
num 0.09 10.26 3.41 5.90 6.52 11.51 3.39 7.98 8.18
num_opt 0.02 7.20 1.28 3.31 3.79 7.09 1.27 5.06 5.28
t10
exp 0.74 ± 0.32 14.77 ± 1.96 0.79 ± 0.45 2.66 ± 0.75 2.49 ± 0.36 19.62 ± 3.28 0.61 ± 0.26 8.63 ± 3.37 9.52 ± 2.89
num 0.20 15.53 5.68 8.76 9.42 16.66 5.66 11.61 11.88
num_opt 0.02 10.21 1.91 4.67 5.39 8.98 1.89 7.15 7.45
Table 4. Experimental and numerical values of PAS: data are reported for the whole data set of test curves for 
each of the defined measurement time points: t0: 0 min, t2: 2 min, t5: 5 min, t10: 10 min; exp: experimental values: 
num: numerical predictions according to23; num_opt: numerical predictions obtained with the optimized set of 
model parameters defined in this study.
Figure 4. Experimental dynamics of SMPA (PAS values over time) of HSD-stimulated platelets as measured 
through the PAS assay; (A) Original_A; (B) Original_B.
www.nature.com/scientificreports/
8Scientific RepoRts | 7: 4994  | DOI:10.1038/s41598-017-05130-5
values of PASt10 (0.79 ± 0.45% and 0.61 ± 0.26% for low_frequency_A and low_frequency_B, respectively), 
which were not statistically different from PASt10 of the NC (p > 0.05).
 (iv) With an increase of SR, even if accompanied by a decrease of SA, as for medium- and high-frequency 
curves, experimental platelet activation revealed a consistent time-response: PAS over time was statistically 
different (p < 0.001) and maximum PASt10 was significantly higher compared to the NC (p < 0.001). A 
non-linear trend of activation was observed, with a shift in the activation rate after 5 min of stimulation.
Numerical predictions of the dynamics of platelet activation. According to our results obtained 
with previously-defined model parameters23 (Fig. 5):
 (i) Numerical simulations predicted a non-incremental PAS rate induced by the NC after 10 min, thus suitably 
emulating the non-activating behavior observed experimentally (Fig. 5A);
 (ii) The numerical activation trend of Original_A and Original_B showed a differing trend with respect to the 
experimental PAS dynamics (Fig. 5B). Numerical PAS values increased suddenly during the first 2 min of 
stimulation, followed by a decrease of the activation rate, whereas this was not seen in vitro. Experimen-
tally, platelet activation remained fairly flat early, then rising rapidly after 5 min. Conversely, the numerical 
model neglected the rapid rise of the platelet activation rate that was observed in vitro after 5 min of stimu-
lation. Despite these discrepancies, numerical values of maximum PASt10 were comparable to experimental 
results.
 (iii) The numerical model predicted a non-negligible rate of activation over time for the low-frequency curves 
(Fig. 5C). The model overestimated maximum PAS (PASt10) with respect to experimental values: numeri-
cal PASt10 of low-frequency_A and low-frequency_B were 7.2-fold and 9.3-fold higher than experimental 
values, respectively.
 (iv) The numerical model predicted a different activation trend for the medium- (Fig. 5D) and high-frequency 
(Fig. 5E) curves versus that which was observed experimentally. The model always predicted a sudden 
increase of platelet activation during the first 2 min of stimulation, which was not observed experimen-
tally. Further, the model overestimated experimental maximum PASt10. Specifically, numerical PASt10 of 
medium-frequency_A and medium-frequency_B were 3.3-fold and 1.3-fold higher than in vitro values, 
respectively; numerical PASt10 of high-frequency_A and high-frequency_B were 3.8-fold and 1.2-fold 
higher than in vitro values, respectively.
The analysis of the contribution of each the model parameters in Equations 5–8 allowed to define a new set 
of constant values reported in Table 3 (labeled as “Optimized”). According to our results, although differences 
in the numerical activation trend persisted (i.e., sudden increase during the first 2 min of stimulation, followed 
by a decrease of the activation rate) previous large errors of numerical PAS values significantly decreased for 
nearly most of the frequency component elements of both Original A and Original B curves (Table 4, Fig. 5C–E). 
In detail, numerical PASt10 were: i) 2.54-fold and 3.09-fold higher for low-frequency A and B, respectively; ii) 
1.75-fold higher and 0.82-fold lower for medium-frequency A and B, respectively; iii) 2.16-fold higher and 
0.78-fold lower for high-frequency A and B, respectively. These values corresponded to a: i) 66% and 67% decrease 
for low-frequency A and B, respectively; ii) 47% and 38% decrease for medium-frequency A and B, respectively; 
iii) 42% and 37% decrease for high-frequency A and B, respectively, with respect to the results obtained with orig-
inal model parameters23. On the other hand, while a good agreement between numerical and experimental PAS10 
was previously observed for Original curves, the new set of constants leads to underestimation of the experimen-
tal values of both Original A and Original B (0.69-fold lower vs 1.05-fold higher and 0.45-fold lower vs 0.85-fold 
lower, with the optimized and original23 values, respectively).
Analysis of the activating potential of SA and SR. In Fig. 6, experimental and numerical PASt10 are 
plotted against values of SA (Fig. 6A) and SR (Fig. 6B) characterizing the shear stress profiles of our data set, 
allowing the selective evaluation of the effects of the two parameters on platelet activation. According to our 
experimental results, an increase in SA does not imply an increase of PAS (Fig. 6A). In contrast, our in vitro data 
demonstrated that PAS continues to increase with increasing values of SR (Fig. 6B). Consistent with this were 
the numeric, i.e. model results - specifically that a progressive increase in platelet activation was observed with 
increasing SR and that a more random association was observed for SA vs PAS, without a specific correlation 
detected.
In Fig. 7, experimental values of PAS t10 are plotted in the SR-SA plane, allowing to comprehensively evaluate 
the effect of simultaneous variation of SA and SR on platelet activation. The results indicate that highest PAS 
values correspond to shear stress profiles characterized by high values of both SA and SR; high SA alone does not 
induce a significant increase of PAS; in contrast it is increasing SR that leads to progressively increased activation 
levels.
Discussion
Thromboembolic complications in cardiovascular BRD recipients are typically multi-factorial involving elements 
of Virchow’s Triad, i.e. endothelial dysfunction and damaged vascular surfaces, inflammatory blood and abnor-
mal flow, compounded by a host of patient-specific factors and issues related to lack of efficacy of anti-platelet 
agents, altered metabolism or insufficient administration of anti-thrombotic pharmacotherapy31–33.
Nonetheless, a dominating factor for thrombogenicity in BRDs are the non-physiologic hemodynamic blood 
flow patterns within these devices, which may induce and potentiate abnormal shear flow-related mechanical 
loading of platelets, eliciting SMPA. Thus, understanding the details of these abnormal flows and the critical 
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components of this stress loading will advance our knowledge on platelet mechanobiology and provide trans-
lational insight as to how to improve BRD design. In fact, understanding the mechanisms that drive alterations 
of platelet function in BRDs may enhance the development of refined design solutions, mitigating the shear 
flow-mediated platelet damage, and minimizing the device-associated thrombogenicity.
The focal nature of platelet activation and thrombosis has long been attributed to the local hemodynamic 
shear stresses, but the exact components of the shear stress signal that contributes to activation with resultant 
thrombus formation have been, to date, difficult to decouple. As a matter of fact, a clear identification of the 
Figure 5. Comparison of numerical predictions of the dynamics of PA over time and experimental in vitro 
values: (A) NC curve; (B) Original curves; (C) low-frequency curves; (D) medium- frequency curves; (E) high-
frequency curves.
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dominant hemodynamic characteristics of shear stress patterns responsible for SMPA in BRDs has as yet not been 
fully accomplished.
The present study extends our understanding of the impact of abnormal shear stresses on platelet activation. 
This is the first study, to our knowledge, that has specifically analyzed the thrombogenic potential of differing 
hemodynamic characteristics of shear stress profiles relevant to therapeutic cardiovascular BRDs. We system-
atically evaluated the platelet response to repetitive mechanical loading associated with the principal frequency 
components of two hemodynamic shear stress waveforms of a PHV. By applying experimentally extracted fre-
quency waveforms (from low to high-frequency components), as well as the original PHV stress curves (com-
posed of the full range of frequency components) we demonstrated that it is the high-frequency components 
that are the major determinants for priming, triggering and yielding activated “prothrombotic behavior” for 
stimulated platelets. Our results suggest that platelets are more sensitive to temporal oscillation of the shear stress 
Figure 6. PAS values (mean ± SD) obtained after a 10-min stimulation period are plotted against values of 
SA (A) and SR (B) characterizing the curves of our data set; SA and SR are reported as for 1 stimulation cycle. 
Numerical PAS values are reported as computed according to ref. 23.
Figure 7. Experimental values of PASt10 are plotted in the SR-SA plane, allowing to comprehensively evaluate 
the effect of simultaneous variations of SA and SR in terms of induced PA: higher PAS values correspond to 
curves characterized by high values of both SA and SR; high values of SA alone do not induce any significant 
increase of PAS; increasing values of SR allows to significantly activate platelets. SA and SR are reported as for 1 
stimulation cycle.
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(i.e., to high SR) even if the imparted shear stress has a relatively lower magnitude and/or briefer exposure time 
(i.e. low SA). Conversely, we showed that SA alone is unlikely to induce a significant activation rate when the 
contribution of SR is limited.
Our experimental results also show that while oscillation frequency (SR), amplitude and exposure time 
(SA) all together contribute to the platelet activity state, they do so though to differing degrees, i.e. with dif-
ferent powers. As observed in Fig. 4, the PAS values for Original waveforms (high SA and SR) are significantly 
greater (p = 0.001) than those associated with the extracted frequency waveforms at 10 min (high SA or high SR). 
Furthermore, the PASt10 values for medium- and high-frequency components of the Original_B waveform are 
more prominent than for Original_A. Examination of the devolved waveforms (Fig. 2) shows that the oscillation 
frequency of medium_frequency_B is greater than that of medium_frequency_A (i.e., higher SR, comparable 
SA), whereas the amplitude of several peaks of high_frequency_B is generally greater than that of high_frequen-
cy_A (i.e., higher SA, comparable SR), with some peaks exceeding 10 dyne/cm2.
The shear stress frequency spectrum proved to be a good predictor of platelet activation; allowing fraction-
ation and decoupling of contributory components of shear stress signals and the subsequent systematic analy-
sis of their contributions to overall platelet activation. Analysis of the hemodynamic components based on the 
signal frequency domain provides insight and may be useful in part to understand the activating potential of 
specific device-associated waveforms. In fact, according to our in vitro experimental results, the sum of PASt10 
for frequency extracted component waveforms falls short of PASt10 for the Original waveforms, with none of 
the devolved waveforms approaching the amplitude (30–40 dyne/cm2) of the Original waveforms. These results 
suggest that the physical impact of shear stress provided by individual spectral frequency components, which are 
sensed and transduced by the platelet, may be less when acting individually versus when acting in concert as a 
full shear stress ensemble, resulting in less damage, poration, signaling or stimulation of mechanotransductive 
mechanisms - all vital biophysical mechanisms involved in platelet activation1. These results additionally gener-
ates hypothesis of reduced triggering of synergistic biochemical events, e.g. ADP release, being attenuated with 
only frequency component stimulation vs full spectrum stimulation.
In support of this differential stress-biochemical coupling effect, Feaver et al. investigated the inflammatory 
response of vascular endothelial cells as a function of the frequency content of wall shear stress in the carotid 
bifurcation34. The results from this study are in good agreement with our findings. Indeed, Feaver and colleagues 
showed that the inflammatory phenotype directly depends on specific components of the frequency domain of 
the shear stress profile34.
The shear stress patterns (i.e., the Original curves) used in this study were extracted by Piatti et al.24 by using 
a Lagrangian model formulation for tracking the platelet trajectories and for computation of the corresponding 
stress patterns. In this study we did not perform a direct comparison with different Lagrangian models pre-
sented in literature, since most of the existing Lagrangian models are based on the power law formulation of 
Grigioni et al.35, which Sheriff et al.22 showed is limited in capturing the shear-mediated platelet activation behav-
ior in response to time-varying shear stress profiles. In addition, in the study by Piatti et al.24, a Lagrangian 
model - and not an Eulerian formulation - was considered as the aim of that study was to characterize the valve 
thrombogenic potential, i.e., to account for the activation of individual platelets, which may have a pro-coagulant 
propensity downstream of the valve. Indeed, as also reported in Hansen et al.36, Lagrangian methods better cap-
ture the accumulated stress histories of individual platelets, thus being better suited for the analysis of plate-
let activation when hot-spot values of shear stress are considered significant. Conversely, the continuum model 
underlying an Eulerian approach would inherently introduce smoothing effects on the computation of the shear 
stress. Furthermore, a Lagangian model formulation allowed us to experimentally test the platelet response to 
shear stress patterns using available equipment - i.e. the HSD, which relies on programmed Lagrangian stress 
waveforms.
Asymmetries can be observed in the shear stress profiles originating from the two commissural ROIs of the 
PHV we analyzed, despite the symmetry in the valve geometry (Fig. 1A). However, this is consistent when con-
sidering that variations in the stress–time waveforms of selected particle trajectories in the commissural ROIs 
can be related to non-negligible asymmetries in kinematics of the aortic leaflets of the valve. Moreover, the use 
of fluid structure interaction (FSI) algorithms may contribute in generating differences in the stress-time wave-
forms. Indeed, when FSI is used to solve high Reynolds number flow problems in regions of complex geometry, 
small numerical perturbations are sufficient to generate flow asymmetry. This phenomenon is similar to that 
attainable with direct numerical simulations (DNS) and is physically consistent. Computational FSI results for 
the aortic valve simulations were reported to be very close to experimental data24. In the study by Piatti et al.24, 
visual inspection of the aortic leaflets in the ViVitro left heart simulator set-up confirmed: i) differences in both 
leaflets fluttering and local surface curvature during systole24, and ii) a clear capture of the clockwise twisting of 
the leaflets free-margin during diastolic closure24. Accordingly, the systolic velocity field exhibits a centered but 
not completely symmetrical flow profile during ejection24.
In this study we were not necessarily concerned with specific locations in the region of the prosthetic valve, 
since this work was not directly aimed at characterizing thrombogenic “hotspots” in the valve. Accordingly, the 
regions selected to extract the Original shear stress curves - i.e., the two commissural regions, represent paradig-
matic shear stress curves that we used to test our hypothesis (different frequency component elements of stress 
patterns drive different platelet activation dynamics). On the other hand, the two Original curves selected in this 
study were known to yield shear stress profiles that are more dynamic and have larger stress accumulation than 
the core flow region where the leaflets meet, thus being particularly fitting to the aim of this study. As such, we 
acknowledge that the experimental results of this study, although providing mechanistic results of platelet func-
tion in response to realistic shear stress waveforms encountered in BRDs, thus overcoming limitations of previous 
works where synthetic shear stress curves were used22, do not extend to a more clinically-pertinent endpoint - i.e., 
the characterization or the minimization of the thrombogenic potential of the specific valve/location in the valve.
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For the measurement of the platelet activation level over consecutive shear-stress stimulation cycles we used 
the PAS assay, which required the use of gel-filtered platelets (GFP), i.e., a platelet suspension deprived of red and 
white blood cells and of plasma coagulation factors. Notably, the use of GFP eliminated other potential sources of 
platelet activation that might influence the description of the platelet-specific activation dynamics. Indeed, while 
the presence of red and white blood cells would increase activation effects due to cell collisions, the presence of 
plasma coagulation factors, which themselves play a role in activation and aggregation, would obfuscate the direct 
shear effect on platelet activation. Furthermore, aggregation or clot formation would reduce the available platelet 
count and change the flow dynamics during the platelet-stimulation tests in the HSD, therefore adding additional 
variables for which the PAS assay, as well as the numerical model we used for comparison of the experimental 
results, would not be able to account. In addition, with GFP we prevented clot formation, which would per se 
amplify the platelet activation levels. With the use of GFP we excluded all those co-factors contributing in vivo to 
platelet activation and characterized selectively the platelet response to shear. Further, the PAS assay, offered sev-
eral advantages with respect to other platelet function tests that use whole blood or plasma, as it uses acetylated 
prothrombin (Ac-FII) as the substrate to quantify the platelet-mediated thrombin production rate: upon exposure 
to activated platelet membranes, Ac-FII is converted to thrombin, which is measured as a marker of activation. 
This represents the distinctive and more innovative feature of PAS assay: the modified thrombin produced by acti-
vated platelets does not further activate platelets27: as such, thrombin generation is a direct indicator of the level of 
activation. The presence of normal thrombin would prevent direct correlation with platelet activation levels, since 
thrombin is a potent agonist of platelet activation and would therefore amplify PAS levels with no correlation with 
the effective shear-mediated effect. In addition, the PAS assay allowed measuring the pro-thrombotic tendency 
of activated platelets without inducing aggregation or clot formation: those mechanisms are precluded due to the 
removal of plasma coagulation factors from GFP preparation. Furthermore, the thrombin produced by Ac-FIIa is 
inactive on fibrinogen and thus cannot mediate the conversion of fibrinogen to fibrin.
Concerning the results of the PAS numerical model, our data indicated that the differential-type PAS pre-
dictive model could effectively resolve a non-linear activation trend induced by complex device-like shear stress 
patterns. However, some differences have been noted with respect to experimental data. A good agreement in 
PAS values was found between numerical and experimental results for Original B and high_frequency B, but 
large errors were calculated for all other waveforms (Fig. 5). For nearly all the cases, numerical predictions over-
estimated in vitro PAS values. Conversely, the optimized constants we defined allowed significantly improved 
fitting of the experimental data, reducing the large errors of numerical PAS values for nearly all the frequency 
component elements of both Original A and Original B (Fig. 5). However, the analysis performed did not provide 
a universal set of model parameters that optimizes numerical results. While the new model coefficients improved 
the prediction for the single frequency components (Fig. 5), they lead to underestimation of PAS values of the 
Original curves (PASt10, Fig. 5). This is consistent with our experimental findings as we experimentally demon-
strated that different frequency components all contribute to the overall PAS but with different powers (i.e., the 
overall PAS is not a linear combination or summation of effects).
Furthermore, numerical results displayed a concave behavior over time, whereas the experimental results 
showed a convex response (Fig. 5) and these differences persisted with the optimized model parameters. This 
discrepancy in the activation trend may be explained by several factors.
First, the model, which serves as a basis for the numerical simulations of this study, was developed for 
shear-mediated activation of human platelets, which showed a concave activating behavior at higher shear stresses 
and frequencies22, 23. In contrast, our work here has been performed with bovine platelets. Moreover, a prior study 
showed a lag in bovine platelet activation under constant shear when compared to human platelets37. Second, the 
model prescribes that the rate of activation increases over time following a logistic saturation process23, which was 
rarely observed experimentally, leading to overestimation of the early (i.e., 0-to-5 min stimulation time) experi-
mental PAS values, and to a progressive decrease of the SMPA rate resulting in different dynamics of activation. 
While it is reasonable to assume that the platelet activation rate would reach an asymptote, whereby all the platelet 
activation components would be exhausted and no further activation would occur, experimental observations 
suggest that platelets have not reached this stage after the 600 stimulation cycles imposed via the HSD.
A further limitation of the numerical model is that it does not consider critical thresholds on shear stress 
amplitude, exposure time and stress variation38. The model places nearly equal emphasis (power) on the differ-
ent hemodynamic characteristics composing the shear stress signal, thus failing to discriminate between differ-
ent - and mutual contributions of SA and SR, overestimating, in particular, the effect associated with high SA 
(low-frequency). However, the current model formulation was tuned according to the experimental evolution of 
PAS in response to shear stress waveforms with higher SA than is used in these simulations23.
The model implies a more continuous, somewhat linear response to early shear stress stimulation. However, in 
biologic reality, it likely takes significant additive damage to cause platelets to become leaky, to sense and to effec-
tively transduce the stress (i.e., to activate). Also, even if damage occurs somewhat early, membranes frequently 
repair themselves and self-seal39, 40, until a threshold of leak is exceeded leading to agonist and electrolyte influx 
and activation. Similarly, the lack of a rapid, progressive early rise of platelet activation for the low frequency 
signals (Fig. 5C) again reemphasizes the importance of intensity of injury and “membrane threshold” for damage 
needed to create poration, opening of channels or effective mechanical transduction. This explanation and con-
cept extends to the observations seen for medium- and high-frequency components as well (Fig. 5C). As such, 
the numeric model assumes continuous progression of early activation, with the same “intensity of activation” 
occurring over the time progression. In contrast, in biological systems, with regard to platelet membrane and 
cytoplasmic dynamics, a threshold response is clearly occurring, hence an initial lag is followed by a much larger 
subsequent response with continued activation. This corresponds and translates to the kinetics of actin assembly, 
pseudopod extension and shape change occurring after a threshold is achieved, then accelerate though with even-
tual plateauing of the response anticipated.
www.nature.com/scientificreports/
13Scientific RepoRts | 7: 4994  | DOI:10.1038/s41598-017-05130-5
On the other hand, numerical PAS results reflect the trend observed in vitro for both SA and SR (Fig. 6), 
although the normalized numerical PAS values are overestimated compared to the experimental PAS. The trend 
observations for SR confirm the earlier findings that an increase in PAS follows an increase in loading rate fre-
quency22. The relationship between PAS and SA is not apparent in our study, and do not reflect the observation 
that an increase in SA leads to an increase in PAS22. However, it is important to note that the strong correlation 
between PAS and SA was achieved previously for more controlled constant or triangular shear stress waveforms22, 23.
To the best of our knowledge, no other numerical predictive models of platelet activation have been reported 
to account for shear stress amplitude and exposure time, stress oscillation frequency and accumulation of plate-
let damage. A simplified version of this numerical model, neglecting the contribution of stress rate, has been 
previously utilized in an Eulerian framework to show that platelet activation in abdominal aortic aneurysms 
accounts for less than 1% of background activation, with good agreement between the Eulerian model and a 
Lagrangian particle tracking approach36. This simplified model was further incorporated into a macroscopic pre-
dictive device-induced thrombus deposition and growth model to account for mechanically-activated paltelets41.
According to the results of this study, we advocate the need to further update the model formulation to specif-
ically address numerical predictions of SMPA associated with loading conditions relevant to BRDs. In addition, 
comparison of bovine and human platelet behavior under realistic BRD-like shear should be accomplished, to 
eventually incorporate observed differences into the numerical model. Furthermore, the model should be inte-
grated with different powers associated with shear stress magnitude, exposure time and stress variation, in order 
to better describe how those parameters individually impact, accumulate and effect platelets. Optimization of the 
numerical model would allow for better in silico estimation of platelet activation in BRDs for improving overall 
thromboresistance. Numerical estimation of platelet activation may be employed during the device design stage 
to compare the effect of modifications of specific geometric features conceived to reduce or eliminate critical flow 
conditions that elicit platelet activation and ultimately the overall device thrombogenic potential.
Conclusion
This study provides a more fundamental understanding of the responsiveness of circulating platelets to the con-
stitutive components of complex shear stress profiles. Further it provides enhanced understanding of platelet 
responsiveness to the hemodynamic environment of BRDs, and the importance of these environments in enhanc-
ing potentially life-threatening thomboembolic complications associated with shear-mediated platelet activation. 
We demonstrated that specific hemodynamic characteristics of hydrodynamic shear stress patterns, namely the 
shear stress oscillation frequency, are major determinants of shear-mediated platelet activation. Moreover, we 
showed that shear stress oscillation frequency, amplitude and exposure time together contribute to activate plate-
lets, but with differing powers. This study provides observations which are useful in further defining basic mecha-
nisms of the platelet mechanobiological response to shear stress. Further, our findings are useful in guiding future 
technological improvements of BRDs. Our experimental results will also serve as the basis for further refinement 
of state-of-the-art numerical PAS predictive models characterizing the shear-mediated phenomenological platelet 
response. Numerical predictive models of PA may represent a valuable, rapid and cost-effective platform to sup-
port and expedite the rational design optimization of local flow dynamics in BRDs.
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